↑ Rising
Business
🔮 fades
Summit Packs A Punch For Merck's Keytruda
Summit Therapeutics and Akeso report that their cancer drug ivonescimab has met overall survival goals in a Phase 3 lung cancer trial.
Cancer Treatment
23 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Cancer Treatment
This hub groups 23 separate news trends connected to Cancer Treatment, spanning June 27, 2026 through September 4, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 158 article observations and 153 source signals, led by Health, Business, Entertainment coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Early-onset bowel cancer shows distinct biological and clinical features - News-Medical
Early-onset bowel cancer exhibits distinct biological and clinical features compared to cases diagnosed in older adults.
◼ Archived
Health
🔮 fades ✓
Morning cancer treatment could boost chances of survival
New research suggests that the time of day cancer treatment is administered could significantly impact patient survival rates.
◼ Archived
Business
🔮 fades ✓
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The FDA's approval of a $480,000-a-year pill for pancreatic cancer has sparked debate over the future of cancer drug pricing.
◼ Archived
Business
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
◼ Archived
Business
Genentech doubles down on ADC-resistance via $1B DualityBio pact
Genentech's $1B bet on DualityBio's ADC technology signals a major shift in cancer treatment strategies.
◼ Archived
Health
🔮 fades ✓
New pancreatic cancer drug that doubled survival time now reaching Charleston patients
A new pancreatic cancer drug that doubled survival time is now available to patients in Charleston.
◼ Archived
Health
🔮 fades ✓
NUS researchers find drug that turns off ‘master switch’ in aggressive breast cancer
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
New data on prostate cancer treatment has divided physicians, with active surveillance rates rising and focal therapy use under scrutiny.
◼ Archived
Health
🔮 fades ✓
New Treatments Show Promise for Two of the Most Deadly Types of Cancer
Eight studies published on August 21, 2026, suggest new hope for patients with brain tumors and another deadly cancer
◼ Archived
Business
🔮 fades ✓
After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next
Moderna's stock surge on a cancer drug breakthrough has Wall Street abuzz with speculation about the future of cancer treatment.
◼ Archived
Business
🔮 fades ✓
Moderna Shares Double on Success of mRNA Cancer Vaccine
Moderna's shares have doubled since August 19th, 2026, as investors react to a breakthrough in cancer treatment.
◼ Archived
Business
🔮 fades ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
◼ Archived
Entertainment
🔮 fades ✓
Craig Melvin Tears Up Live on the “Today” Show, Reveals His Mom Betty ‘Rang the Bell’ for the End of Her Cancer Treatment
Craig Melvin's emotional moment on the 'Today' show has viewers reflecting on the power of family and resilience.
◼ Archived
Health
Cancer treatment delays surge across US as doctor warns system ‘needs fixing immediately’
Cancer patients in the US are facing increasing delays in treatment, with one doctor calling for immediate system reforms.
◼ Archived
Health
🔮 fades ✓
Patients receive ‘historic’ pill for deadly pancreatic cancer
Patients with pancreatic cancer are receiving a new pill treatment, marking a significant milestone in cancer therapy.
◼ Archived
Business
🔮 fades ✓
FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
Bristol Myers Squibb's new multiple myeloma drug Zenbexus™ debuts as a novel treatment class, but the company faces financial pressure from generic competition.
◼ Archived
Entertainment
Jon Batiste cancels Friday concert at Highmark Mann Center
Grammy-winning musician Jon Batiste has abruptly canceled several upcoming concerts, including a show in Philadelphia.
◼ Archived
Health
🔮 fades ✓
Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.
◼ Archived
Health
🔮 fades ✓
Cancer-fighting antibodies with a one-two punch take aim at tumours
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
◼ Archived
Health
🔮 fades ✓
Modular in vivo antibody–ADC click to reverse drug resistance in tumours
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers
Recent studies suggest GLP-1 receptor agonists may slow cancer progression in obesity-related cases.
◼ Archived
Technology
🔮 fades ✓
The fittest founder in the room got cancer. Here’s how he used AI to fight back.
Entrepreneur Conno Christou is utilizing AI to navigate a cancer diagnosis despite maintaining a rigorous health and biomarker tracking regimen.